Cost effectiveness of amoxicillin for lower respiratory tract infections in primary care: an economic evaluation accounting for the cost of antimicrobial resistance.

Journal article

Background

Lower respiratory tract infections (LRTIs) are a major disease burden and are often treated with antibiotics. Typically, studies evaluating the use of antibiotics focus on immediate costs of care, and do not account for the wider implications of antimicrobial resistance.

Aim

This study sought to establish whether antibiotics (principally amoxicillin) are cost effective in patients with LRTIs, and to explore the implications of taking into account costs ...

Expand abstract

Authors: Oppong, R; Smith, R; Little, P; Verheij, T; Butler, C

• Publication status: Published
• Peer review status: Peer reviewed
• Publisher: Royal College of General Practitioners
• Journal: British Journal of General Practice
• Volume: 66
• Issue: 650
• Pages: e633-e639
• Publication date: 2016-08-01
• Acceptance date: 2016-04-06
• DOI: 10.3399/bjgp16x686533
• EISSN: 1478-5242
• ISSN: 0960-1643
• Pmid: 27402969
• Language: English
• Keywords: Respiratory Tract Infections; Double-Blind Method; Humans; Anti-Bacterial Agents; Middle Aged; Models, Economic; Cost-Benefit Analysis; Drug Resistance, Bacterial; Microbial Sensitivity Tests; Primary Health Care; Amoxicillin; Health Care Costs; Europe